GlassScriptPhysician profile
Kimberly A Robertson
NPI 1407333446
$8,525.98
in general payments reported to CMS, 2019-2025
60 companies · $3,560 in 2025
The $3,560 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.04 · 2022: $1,166 · 2023: $1,925 · 2024: $1,855 · 2025: $3,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,071 · Travel and Lodging: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,071.02 |
| Travel and Lodging | $267.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,651.90 | 2022-2025 | |
| Pfizer INC. | $586.50 | 2023-2025 | |
| Livanova USA, INC. | $541.41 | 2023 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neurocrine Biosciences, INC. | $508.42 | 2022-2025 | Ingrezza, Ongentys |
| Ucb, INC. | $415.35 | 2024-2025 | Fintepla, Briviact, Rystiggo |
| Argenx US, INC. | $345.23 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $307.35 | 2022-2025 | Ultomiris, Strensiq |
| Lilly USA, LLC | $289.30 | 2022-2025 | Emgality, Reyvow, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $279.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $271.96 | 2022-2025 | |
| Celgene Corporation | $239.30 | 2022-2025 | Zeposia |
| Biogen, INC. | $229.25 | 2022-2025 | Vumerity, Tysabri, Skyclarys |
| Sk Life Science, INC. | $215.59 | 2022-2025 | |
| Novo Nordisk INC | $208.66 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $185.84 | 2023-2025 | Wainua, Farxiga |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $179.74 | 2023-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $138.74 | 2025 | Nuplazid |
| Amgen INC. | $130.90 | 2022-2025 | Repatha, Evenity, Prolia |
| Eisai INC. | $129.33 | 2023 | |
| Sumitomo Pharma America, INC. | $101.15 | 2023-2024 | Aptiom |
| Mannkind Corporation | $92.34 | 2023 | Afrezza |
| Neurelis, INC. | $90.23 | 2024-2025 | Valtoco |
| Janssen Biotech, INC. | $88.69 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $81.45 | 2023 | Fycompa |
| Ani Pharmaceuticals, INC. | $75.77 | 2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $73.60 | 2025 | Ocrevus Zunovo |
| Sanofi-Aventis U.S. LLC | $73.22 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $72.95 | 2024-2025 | Acthar |
| Cala Health, INC. | $72.56 | 2025 | Cala Kiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.83 | 2023-2024 | Tradjenta, Jardiance |
| Dexcom, INC. | $52.25 | 2024 | Dexcom G6 Transmitter |
| Genzyme Corporation | $52.23 | 2025 | |
| Banner Life Sciences, LLC | $42.90 | 2021-2022 | |
| Springworks Therapeutics, INC. | $40.54 | 2025 | Gomekli |
| Xeris Pharmaceuticals, INC. | $39.15 | 2022-2024 | Gvoke Hypopen |
| Grifols USA, LLC | $36.60 | 2025 | Gamunex-C |
| Tanabe Pharma America, INC. | $31.41 | 2025 | Radicava |
| Scilex Pharmaceuticals INC. | $30.72 | 2024 | |
| Cycle Pharmaceuticals INC | $30.30 | 2025 | Tascenso Odt |
| Bayer Healthcare Pharmaceuticals INC. | $28.48 | 2023 | |
| Tandem Diabetes Care, INC. | $26.78 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Csl Behring | $26.24 | 2024 | Hizentra |
| Merz Pharmaceuticals, LLC | $25.12 | 2025 | Xeomin |
| Upsher-Smith Laboratories LLC | $25.00 | 2022 | |
| Lifescan, INC. | $24.90 | 2023 | |
| Janssen Pharmaceuticals, INC | $24.53 | 2022 | |
| Harmony Biosciences LLC | $23.68 | 2025 | |
| Corcept Therapeutics | $22.91 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $21.67 | 2025 | Austedo Xr |
| Vanda Pharmaceuticals INC. | $21.28 | 2025 | Ponvory |
| Otsuka America Pharmaceutical, INC. | $20.08 | 2025 | Rexulti |
| Mdd US Operations, LLC | $19.70 | 2025 | Qelbree |
| Cequr Corporation | $17.22 | 2024 | Cequr Simplicity |
| Axsome Therapeutics, INC. | $16.50 | 2025 | Symbravo |
| Amneal Pharmaceuticals LLC | $15.10 | 2023 | Rytary |
| Insulet Corporation | $14.15 | 2022 | |
| Avanir Pharmaceuticals, INC. | $13.98 | 2022 | |
| Glaxosmithkline, LLC. | $13.47 | 2024 | Trelegy Ellipta |
| Halozyme INC | $13.43 | 2023 | |
| Supernus Pharmaceuticals, INC. | $12.51 | 2022 | Tlando, Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.